Mesenchymal stromal cells (MSCs) are currently being investigated in numerous clinical
trials of tissue repair and various immunological disorders based on their ability to secrete …

The strategy of using mesenchymal stem cells (MSCs) as a living carrier for active delivery of
therapeutic agents targeting tumor sites has been attempted in a wide range of studies to …

Mesenchymal stem cells (MSCs) are among the most investigated and applied somatic stem
cells in experimental therapies for the regeneration of damaged tissues. Moreover, as it was …

Stromal cell-derived factor-1 (SDF-1) and its receptor, CXC chemokine receptor-4 (CXCR4),
are important regulators in the migration of bone marrow mesenchymal stem cells (BMSCs) …

Glioma accounts for nearly 80% of all intracranial malignant tumors. It is a major challenge
to society as it is causes to impaired brain function in many patients. Currently, gliomas are …

Background Newcastle disease virus (NDV) is an avian paramyxovirus, which selectively
exerts oncolytic effects in cancer cells. Mesenchymal stem cells (MSCs) have been reported …

Although the infiltration of mesenchymal stem (stromal) cells (MSCs) into different tumors is
widely recognized in animal models, the question whether these MSCs have a positive or …

Background Hair follicle stem cells (HFSCs) are considered as a promising cell type in the
stem cell transplantation treatment of neurological diseases because of their rich sources …

Immune checkpoint blockade (ICB) necessitates a thorough understanding of intricate
cellular interactions within the tumor microenvironment (TME). Mesenchymal stromal cells …

Neural tube defects (NTDs) lead to prenatal mortality and lifelong morbidity. Currently,
surgical closure of NTD lesions results in limited functional recovery. We previously …